ArticleiScience2026
From pre-tumor to tumor: Decoding the endoscopic-pathologic spectrum of neoplastic lesions in autoimmune gastritis.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune gastritis (AIG) is a chronic atrophic gastritis predisposing to neuroendocrine tumors (NETs), dysplasia, and gastric cancer (GC). In a cohort of 1,551 patients with suspected AIG, we identified 46 with neoplastic lesions and 134 without such lesions and compared their clinicopathological and endoscopic features. NETs typically appeared as polypoid/submucosal tumors with dilated vessels or central depression; epithelial neoplasms showed variable morphologies, with irregular microvessels under narrow-band imaging (NBI). Extensive corpus atrophy and antral patchy redness were independent risk factors for AIG-associated neoplasia, whereas female sex was protective. These findings support a risk model integrating clinical, endoscopic, and pathological features for individualized surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.